Sabalde, Rey Anthony .
HRN: 10-79-97 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2023
CEFUROXIME 750MG (VIAL)
03/13/2023
03/19/2023
IV
750mg
IV
Multiple Soft Tissue Injuries Sec To MVA
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Dose Wrong Dose
Overall appropriateness: No Wrong Dose